<?xml version="1.0"?>
<DEBATE-SPEECH>
  <BILL>
    <TITLE> Medicinal products for paediatric use</TITLE>
    <CODE>A6-0247/2005</CODE>
    <DATE>2005-09-07</DATE>
    <ITEM>9</ITEM>
    <RAPPORTEUR>Françoise GROSSETETE</RAPPORTEUR>
    <ISSUEAREA>4</ISSUEAREA>
    <PASSED>1</PASSED>
    <RCV>0</RCV>
  </BILL>
  <SPEAKER>
    <NAME>President</NAME>
    <COUNTRY></COUNTRY>
    <GROUP></GROUP>
    <STATUS>
      <ISPRESIDENT>1</ISPRESIDENT>
      <ISCOUNCIL>0</ISCOUNCIL>
      <ISCOMMISSION>0</ISCOMMISSION>
      <ISOTHERBUREAUCRAT>0</ISOTHERBUREAUCRAT>
      <ISRAPPORTEUR>0</ISRAPPORTEUR>
      <ISCOMMITTEEREP>0</ISCOMMITTEEREP>
      <ISAUTHOR>0</ISAUTHOR>
      <ISONBEHALFOFGROUP>0</ISONBEHALFOFGROUP>
    </STATUS>
  </SPEAKER>
  <SPEAKER-NUMBER>1</SPEAKER-NUMBER>
  <TEXT>
    The next item is the debate on the report by Mrs Grossetête on the proposal for a regulation of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004 (COM(2004)0599 – C6-0159/2004 – 2004/0217(COD)) ( A6-0247/2005 ).
  </TEXT>
</DEBATE-SPEECH>

